Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

Posted on February 9, 2023 By News Desk

BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics. CINtec PLUS Cytology is the only FDA-approved dual-stain triage test for patients who have a high-risk human papillomavirus (HPV) result. The test is commercially available for ordering by healthcare providers through BioReference, and its specialty division, G(…..) Continue reading »

PR Newswire

Post navigation

Previous Post: 8-K Earnings – Philip Morris International Inc. (0001413329) February 09
Next Post: 8-K Earnings Reg FD – Shutterstock, Inc. (0001549346) February 09

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • Ecolab Survey Reveals High Expectations for Water Conservation
  • 8-K Vote Other Events – CASI Pharmaceuticals, Inc (DE) (0000895051) March 20
  • Sotera Health Amends and Upsizes Revolving Credit Facility
  • COGNYTE INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Cognyte Investors of a Class Action Lawsuit and Upcoming Deadline
  • Investigation announced for Long-Term Investors in shares of Enovix Corporation (NASDAQ: ENVX)

Copyright © 2023 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version